Pricing Log in Create free account

Champions Oncology, Inc. (CSBR) vs Nomad Power Solutions, Inc. (NMAD)

Champions Oncology, Inc. and Nomad Power Solutions, Inc. are both Biotechnology companies. Champions Oncology, Inc. and Nomad Power Solutions, Inc. are of similar size ($66.7M and $65.9M). Nomad Power Solutions, Inc. has the higher net margin (0.00% vs −1.87%) and the higher return on invested capital (−40.4% vs −626.2%). Across the 12 metrics below, Nomad Power Solutions, Inc. leads on 7 and Champions Oncology, Inc. on 5.

Valuation

Metric CSBR NMAD Biotechnology median
P/E n/m n/m 8.50
P/S 1.08 n/m 9.71
P/B 14.65 2.09 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 196.33 n/m 0.64
EV/Sales 1.01 n/m 9.21
Earnings yield (1.70%) (25.77%) (33.15%)
Free cash flow yield (9.36%) (10.44%) (25.50%)

Profitability

Metric CSBR NMAD Biotechnology median
Gross margin 49.82% — 65.16%
Operating margin (1.68%) 0.00% 0.00%
Net margin (1.87%) 0.00% 0.00%
Free cash flow margin (10.08%) 0.00% 0.00%
Return on equity (28.38%) (68.04%) (56.36%)
Return on assets (3.56%) (62.67%) (48.04%)
Return on invested capital (626.23%) (40.41%) 0.00%

Growth

Metric CSBR NMAD Biotechnology median
Revenue growth (TTM) 6.65% — 6.02%
EPS growth (last fiscal year) (124.24%) 20.75% 30.26%
Revenue growth, 5-year CAGR 7.68% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CSBR NMAD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.03 12.87 4.72
Net debt to EBITDA (20.56) 1.00 0.96

Dividend

Metric CSBR NMAD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CSBR NMAD Biotechnology median
Market cap 66.67m 65.85m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack